GASTROINTESTINAL NEUROENDOCRINE TUMOUR

This adverse event was reported 65 times

GASTROINTESTINAL NEUROENDOCRINE TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SEPIAPTERIN 1 0.0053
1 DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM 1 0.0027
2 BODY CLEANSER 1 0.0014
3 DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG 1 0.0011
4 ESOMEPRAZOLE SODIUM 2 0.0008
5 FERRIC DERISOMALTOSE 1 0.0007
6 LUTETIUM LU 177 DOTATATE 4 0.0007
7 AXICABTAGENE CILOLEUCEL 5 0.0005
8 INSULIN LISPRO-AABC 1 0.0005
9 SKIN PROTECTANT 1 0.0004
See all drugs enriched for association with GASTROINTESTINAL NEUROENDOCRINE TUMOUR